Home › Eurofins Panlabs Strengthens Drug Discovery Services With GE Healthcare's Cytiva Cardiomyocytes
 

Keywords :   


Eurofins Panlabs Strengthens Drug Discovery Services With GE Healthcare's Cytiva Cardiomyocytes

2013-07-31 08:51:41| drugdiscoveryonline News Articles

Eurofins Scientific (EUFI.PA), the world leader in food, environment and pharmaceutical products testing, has signed an agreement with GE Healthcare for the exclusive right to offer GE Healthcare’s Cytiva Cardiomyocytes for drug discovery and early development cardio toxicity screening services

Tags: services drug discovery drug discovery

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Businessman Tony O'Reilly dies after short illness
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »